Your browser doesn't support javascript.
loading
Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults.
Lamble, Adam J; Schultz, Liora M; Nguyen, Khanh; Hsieh, Emily M; McNerney, Kevin; Rouce, Rayne H; Gardner, Rebecca A; Ghorashian, Sara; Shah, Nirali N; Maude, Shannon L.
Affiliation
  • Lamble AJ; Division of Hematology/Oncology, Seattle Children's Hospital, Seattle, WA.
  • Schultz LM; Division of Pediatric Hematology/Oncology, Stanford University, Stanford, CA.
  • Nguyen K; Division of Pediatric Hematology/Oncology, Stanford University, Stanford, CA.
  • Hsieh EM; Division of Hematology/Oncology, Children's Hospital of Los Angeles, Los Angeles, CA.
  • McNerney K; Division of Hematology, Oncology, and Stem Cell Transplantation, Lurie Children's Hospital, Chicago, IL.
  • Rouce RH; Center for Cell and Gene Therapy, Texas Children's Hospital, Houston, TX.
  • Gardner RA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Ghorashian S; Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom.
  • Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
  • Maude SL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA.
Blood Adv ; 8(13): 3544-3548, 2024 Jul 09.
Article in En | MEDLINE | ID: mdl-38701425

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Blood Adv Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive Limits: Adolescent / Adult / Child / Female / Humans / Male Language: En Journal: Blood Adv Year: 2024 Document type: Article
...